216 related articles for article (PubMed ID: 24707115)
1. High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.
Aliagas E; Vidal A; Texidó L; Ponce J; Condom E; Martín-Satué M
Mediators Inflamm; 2014; 2014():509027. PubMed ID: 24707115
[TBL] [Abstract][Full Text] [Related]
2. The role of the CD39-CD73-adenosine pathway in liver disease.
Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
[TBL] [Abstract][Full Text] [Related]
3. High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.
Bareche Y; Pommey S; Carneiro M; Buisseret L; Cousineau I; Thebault P; Chrobak P; Communal L; Allard D; Robson SC; Mes-Masson AM; Provencher D; Lapointe R; Stagg J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771891
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study.
Lima CF; Tamegnon A; Rodriguez S; Maru D; Martin PL; Cooper ZA; Rodriguez-Canales J; Parra ER
Pathobiology; 2024; 91(3):205-218. PubMed ID: 37926083
[TBL] [Abstract][Full Text] [Related]
5. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
[TBL] [Abstract][Full Text] [Related]
6. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
[TBL] [Abstract][Full Text] [Related]
7. Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes.
Pasquini S; Vincenzi F; Casetta I; Laudisi M; Merighi S; Gessi S; Borea PA; Varani K
Cells; 2020 Apr; 9(5):. PubMed ID: 32344922
[TBL] [Abstract][Full Text] [Related]
8. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
[TBL] [Abstract][Full Text] [Related]
9. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
10. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI
Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium.
Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627
[TBL] [Abstract][Full Text] [Related]
13. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ecto-nucleotidases in human oviducts with an improved approach simultaneously identifying protein expression and in situ enzyme activity.
Villamonte ML; Torrejón-Escribano B; Rodríguez-Martínez A; Trapero C; Vidal A; Gómez de Aranda I; Sévigny J; Matías-Guiu X; Martín-Satué M
Histochem Cell Biol; 2018 Mar; 149(3):269-276. PubMed ID: 29273916
[TBL] [Abstract][Full Text] [Related]
15. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death.
Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S
Blood; 2011 Dec; 118(23):6141-52. PubMed ID: 21998208
[TBL] [Abstract][Full Text] [Related]
16. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
17. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.
Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420
[TBL] [Abstract][Full Text] [Related]
18. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
20. Variability in CD39 and CD73 protein levels in uveal melanoma patients.
Harou O; Cros-Perrial E; Alix E; Callet-Bauchu E; Bertheau C; Dumontet C; Devouassoux-Shisheboran M; Jordheim LP
Nucleosides Nucleotides Nucleic Acids; 2022; 41(11):1099-1108. PubMed ID: 35199627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]